Alaunos Therapeutics Inc (TCRT)

US · Healthcare · Biotechnology

$1.60+25.00%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-952,000

EPS

$-0.41

Market cap

$3.6M

Forward P/E

18.5

P/B

5.49

Book value

$0.54

EPS (TTM)

$-1.66

52-week high

$4.59

52-week low

$1.28

50-day MA

$1.86

200-day MA

$2.64

Beta

-0.97

Analysts rate Alaunos Therapeutics Inc a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $1.75.

Insiders

15.30%

Institutions

4.88%

Fund	Stake
Geode Capital Management, LLC	0.89%
BlackRock Inc	0.84%
Vanguard Fiduciary Trust Co	0.61%
Vanguard Capital Management, LLC	0.55%
HRT FINANCIAL LLC	0.52%
Two Sigma Investments LLC	0.43%
Citadel Advisors Llc	0.41%
XTX Topco Ltd	0.40%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Alaunos Therapeutics Inc — free to start.

Data updated 2026-09-18.